Search alternatives:
ns decrease » nn decrease (Expand Search), we decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
6 decrease » 026 decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 ns » 50 ms (Expand Search)
ns decrease » nn decrease (Expand Search), we decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
6 decrease » 026 decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 ns » 50 ms (Expand Search)
-
1
Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production.
Published 2021Subjects: -
2
-
3
-
4
-
5
ku0063794 but not rapamycin decreased the TRPC6 mRNA levels in podocytes.
Published 2014“…<p>(A) ku0063794 (2 µmol/l) or rapamycin (50 nmol/l) was applied to evaluate the effects of mTORC1 and mTORC2 on TRPC6 in podocytes. …”
-
6
-
7
-
8
-
9
AAV-mediated Atp6v1c1 knockdown decreased TRAP positive cells and Atp6v1c1 expression in the periodontitis lesion area.
Published 2015“…<p>(A) TRAP staining was used to indicate the decrease in Atp6v1c1 expression in periodontal tissues after AAV-sh-Atp6v1c1 knockdown. …”
-
10
Decreased macrophage recruitment correlates with decreased angiogenesis.
Published 2013“…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”
-
11
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…(L) Quantitative RT-PCR showing the expression level of several flow-responsive genes after lidocaine treatment. <i>klf2a</i> expression is significantly decreased after 6 and 10 h of treatment and is restored by incubation at 34°C; 100% of expression corresponds to a normal expression level. …”
-
12
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20